Physician profile
Stefan Riedel
NPI 1265647838
$134,887.11
in general payments reported to CMS, 2019-2025
8 companies · $34K in 2025
The $34K reported for 2025 was more than what 93% of Clinical Pathology providers received nationally (typical 2025 total: $116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $26K · 2021: $6,708 · 2022: $6,375 · 2023: $19K · 2024: $19K · 2025: $34K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $23K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Consulting Fee: $19K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $10K · Food and Beverage: $1,016.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $23,490.84 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,850.00 |
| Consulting Fee | $18,598.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $10,350.00 |
| Food and Beverage | $1,015.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $62,936.61 | 2023-2025 | Alinity M, Id Now Instrument |
| Opgen, INC. | $61,932.50 | 2019-2023 | |
| Fisher Scientific Company L.L.C. | $3,500.00 | 2020-2022 | |
| Shionogi INC | $2,677.00 | 2023-2025 | Fetroja |
| Cepheid | $1,633.00 | 2023-2025 | Xpert Xpress Strep A |
| Pfizer INC. | $1,275.00 | 2024 | |
| Becton, Dickinson and Company | $933.00 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stefan Riedel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.